These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3180817)
21. Factors modifying the secretion and action of parathyroid hormone in renal failure. Cundy TF; Hamdy NA; Kanis JA Contrib Nephrol; 1988; 64():5-15. PubMed ID: 3053038 [No Abstract] [Full Text] [Related]
22. [Pathophysiology and treatment of renal osteodystrophy]. Ionova D Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143 [No Abstract] [Full Text] [Related]
23. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism]. de Vernejoul MC Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587 [TBL] [Abstract][Full Text] [Related]
24. Bone biopsy studies in the diagnosis and treatment of renal osteodystrophy. Sebert JL; Fardellone P; Noel C; Cohen-Solal M; Bellony R; Marie A; Fournier A Contrib Nephrol; 1988; 64():49-57. PubMed ID: 3180824 [No Abstract] [Full Text] [Related]
25. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. McCarley PB; Arjomand M Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764 [TBL] [Abstract][Full Text] [Related]
26. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients]. Goto S; Fukagawa M Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657 [TBL] [Abstract][Full Text] [Related]
27. Renal osteodystrophy: past and future. Slatopolsky E; Lopez-Hilker S; Dusso A; Brown A; Delmez J; Martin K Contrib Nephrol; 1990; 78():38-45; discussion 45-6. PubMed ID: 2225842 [No Abstract] [Full Text] [Related]
28. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol. Bordier PJ; Marie PJ; Arnaud CD Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669 [No Abstract] [Full Text] [Related]
29. [Prevention and treatment of renal osteodystrophy: present and future]. Fernández E; Craver L Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423 [No Abstract] [Full Text] [Related]
30. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Salusky IB; Coburn JW; Brill J; Foley J; Slatopolsky E; Fine RN; Goodman WG Kidney Int; 1988 May; 33(5):975-82. PubMed ID: 3392886 [TBL] [Abstract][Full Text] [Related]
31. How important is phosphate in the pathogenesis of renal osteodystrophy? Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572 [No Abstract] [Full Text] [Related]
32. Relative hypoparathyroidism and adynamic bone disease. Mucsi I; Hercz G Am J Med Sci; 1999 Jun; 317(6):405-9. PubMed ID: 10372841 [TBL] [Abstract][Full Text] [Related]
36. Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Milliner DS; Nebeker HG; Ott SM; Andress DL; Sherrard DJ; Alfrey AC; Slatopolsky EA; Coburn JW Ann Intern Med; 1984 Dec; 101(6):775-9. PubMed ID: 6208838 [TBL] [Abstract][Full Text] [Related]
37. [Renal osteodystrophy: bone disease with renal disease]. Shigematsu T Nihon Rinsho; 2002 Mar; 60 Suppl 3():435-42. PubMed ID: 11979940 [No Abstract] [Full Text] [Related]
38. Parathyroid dysfunction end stage renal disease. DiTella PJ; Lang GR Otolaryngol Clin North Am; 1980 Feb; 13(1):193-201. PubMed ID: 7367004 [No Abstract] [Full Text] [Related]